SlideShare a Scribd company logo
1 of 28
Acute Asthma Exacerbation:
• Bronchial Asthma : consist of broncho spasm
& airway inflammation.
• Asthma exacerbations consist of acute or
subacute episodes of progressively worsening
shortness of breath, coughing, wheezing, and
chest tightness or any combination thereof.
Clinical Assessment
• Focused History.
• Physical examination findings: vital signs,
Respiratory distress& Chest examination.
• Pulse oximetry & PEFR
• Lung function (defer in patients with
moderate to severe distress or history of labile
disease)
• Often, asthma exacerbations worsen during sleep
(between midnight and 8 am), when airways
inflammation and hyperresponsiveness are at
their peak.
• A severe exacerbation of asthma that does not
improve with standard therapy is termed status
asthmaticus.
• The biologic, environmental, economic, and
psychosocial risk factors associated with asthma
morbidity and death can further guide this
assessment.
Acute Asthma Exacerbation:
Acute Asthma Exacerbation:
Assessment and Severity
• Severity range: mild  mod severe
• Treatment : outpatient, inpatient (floor or
ICU)
• Severity: Clinical, ABG, PEFR ( ≥ 70%, 40-69%,
< 40%)
• A chest radiograph is not recommended for
routine assessment but should be obtained
for patients suspected of having congestive
heart failure, pneumothorax/mediastinum,
pneumonia.
Assessment of Severity
In general ???
 There are two main types of drugs used for treating asthma.
Medications to reduce bronchoconstrictions:
o Beta 2 Agonist
o Anticholinergics
o Theophylline
Medications to reduce inflammations:
o Steroids ( oral, Parenteral & Inhalers)
o Not steroids:
• Leukotriene modifiers ( montelukast is available worldwide;
zafirlukast and pranlukast only in Japanese Guideline for Childhood
Asthma(JGCA).
 Cromolyn & Nedocromil (Reduction of mast cell degranulation)
Farther more ???
 Quick- relief medications:
o Short acting Beta Agonists (SABA’s)
o Systemic corticosteroids
o Anticholinergics
 Long-term control medications:
o Corticosteroids (mainly ICS, occasionally OCS).
o Long Acting Beta Agonists (LABA’s) including salmeterol and
formoterol,
o Leukotriene Modifiers (LTM)
o Cromolyn & Nedocromil
o Methylxanthines: (Sustained-release theophylline)
paediatric ICU
paediatric word
EMERGENCY DEPARTMENT
Home
Case scenario ?
• Ali 10 years old , a known case of bronchial
asthma
• Develop cough and SOB for 12 hours duration
after flue like illness & exposure to smock.
• O/E: in respiratory distress.
Home Management of Asthma Exacerbations
• Families of all children with asthma should have a
written action plan.
• A written home action plan can reduce the risk of
asthma death by 70%.
• The NIH guidelines recommend immediate
treatment with “rescue” medication (inhaled
SABA, up to 3 treatments in 1 hr).
• A good response is characterized by: resolution
of symptoms within 1hr, no further symptoms
over the next 4 hr.
Farther more ….
• Ali become better but still have cough & SOB
& bronchodilators are required repeatedly
over the next 24 hr.
• The child's physician should be contacted for
follow-up, especially if bronchodilators are
required repeatedly over the next 24-48 hr.
• Short course of oral corticosteroid therapy
(prednisone 1-2 mg/kg/day for 4 days) in
addition to inhaled β-agonist therapy should
be instituted.
Home Management of Asthma Exacerbations
Ali develop severe exacerbations&
deterioration
persistent signs of respiratory distress,
lack of expected response or sustained
improvement after initial treatment,
Immediate medical attention should be
sought for: ( call 122 )
Home Management of Asthma Exacerbations
• Initial treatment includes:
• supplemental oxygen,
• inhaled β-agonist therapy every 20 min for
1 hr, and,
• systemic corticosteroids given either orally or
intravenously.
• Close monitoring of clinical status, hydration,
and oxygenation are essential elements of
immediate management.
Emergency Department Management
of Asthma Exacerbations
• The patient may be discharged to home if there
is sustained improvement in symptoms, normal
physical findings, an oxygen saturation >92%
while the patient is breathing room air for 4 hr.
• Discharge medications include administration of
an inhaled β-agonist up to every 4 hr plus a 3-to
7-day course of an oral corticosteroid.
• Optimizing controller therapy before discharge is
also recommended.
Emergency Department Management
of Asthma Exacerbations
• Ali has poor response to intensified treatment
suggests that the exacerbation will not remit
quickly.
• Inhaled ipratropium: added to the β-agonist &
corticosteroid treatment.
Emergency Department Management
of Asthma Exacerbations
Hospital Management of Asthma
Exacerbations
• Ali does not adequately improve within 2 hr of
emergency department treatment, admission
to the hospital, at least overnight, is likely to
be needed.
• β-agonist up to every 4 hr
• Inhaled ipratropium 6 hr
• Corticosteroid IV (Oral)
• Ali deteriorated at unit & developed severe
respiratory distress, poor response to therapy,
and concern for potential respiratory failure
and arrest.
He need admission to an intensive care unit
Hospital Management (ICU)of Asthma
Exacerbations
Ali : require additional evaluations, such as
complete blood cell counts,
measurements of arterial blood gases and
serum electrolytes, and
chest radiograph,
to monitor for respiratory insufficiency, co-
morbidities, infection, and/or dehydration.
Hospital Management of Asthma
Exacerbations
• the conventional interventions for status
asthmaticus are:
• Supplemental oxygen, high-flow oxygen.
• SABAs can be delivered frequently (every
20 min)
• May need intravenous β-agonist therapy.
• Inhaled ipratropium bromide every 6 hr.
• systemic corticosteroid therapy
• Patients requiring cardiac monitoring &
oximetry.
Hospital Management of Asthma
Exacerbations
Nelson Textbook of Pediatrics, 20th edition, page 1114.
According to Nelson Textbook of
Pediatrics, 21th edition 2019
 The addition of ICS to a course of oral corticosteroid
in the emergency setting , reduces the risk of
exacerbation recurrence over the subsequent
month.
• Hydration status monitoring is especially
important (insensible losses) and decreased oral
intake but
• Further complicating this situation is the
association of increased antidiuretic hormone
(ADH) secretion with status asthmaticus.
• Administration of fluids at or slightly below
maintenance fluid requirements is
recommended.
• Chest physical therapy, and mucolytics are not
recommended .
Hospital Management of Asthma
Exacerbations
• Despite intensive therapy, some asthmatic
children remain critically ill and at risk for
respiratory failure, intubation, and mechanical
ventilation.
• Complications (air leaks) related to asthma
exacerbations increase with intubation and
assisted ventilation; every effort should be
made to relieve bronchospasm and prevent
respiratory failure.
Hospital Management of Asthma
Exacerbations
• Several therapies, including parenterally administered
• Epinephrine: Parenteral (subcutaneous, intramuscular, or
intravenous) epinephrine may be effective in patients with life-
threatening obstruction that is not responding to high doses of
inhaled β-agonists, because in such patients, inhaled medication
may not reach the lower airway.
• methylxanthines,
• magnesium sulfate (25-75 mg/kg, maximum dose 2.5 g, given
intravenously over 20 min), and
• inhaled heliox have demonstrated some benefit as adjunctive
therapies in patients with severe status asthmaticus.
• Administration of either methylxanthine or magnesium sulfate
requires monitoring of serum levels and cardiovascular status.
Hospital Management of Asthma
Exacerbations
• Volume-cycled ventilators, using
• short inspiratory and long expiratory times,
• 10-15 mL/kg tidal volume,
• 8-15 breaths/min,
• peak pressures < 60 cm H2O, and without positive
end-expiratory pressure are starting mechanical
ventilation parameters that can achieve these
goals.
Hospital Management of Asthma
Exacerbations
• In children, management of severe exacerbations
in medical centers is usually successful, even
when extreme measures are required.
• A follow-up appointment within 1 to 2 wk of a
child's discharge from the hospital after
resolution of an asthma exacerbation should be
used to monitor clinical improvement and to
reinforce key educational elements, including
action plans and controller medications.
Hospital Management of Asthma
Exacerbations
THANKS FOR YOUR
ATTENTION

More Related Content

What's hot (20)

Asthma
AsthmaAsthma
Asthma
 
Pulmonary Oedema - Pathophysiology - Approach & Management
Pulmonary Oedema  - Pathophysiology - Approach & ManagementPulmonary Oedema  - Pathophysiology - Approach & Management
Pulmonary Oedema - Pathophysiology - Approach & Management
 
Aspiration Pneumonia
Aspiration PneumoniaAspiration Pneumonia
Aspiration Pneumonia
 
Asthma
Asthma Asthma
Asthma
 
Cough
Cough Cough
Cough
 
Cough
CoughCough
Cough
 
Mechanical ventilation
Mechanical ventilationMechanical ventilation
Mechanical ventilation
 
Acute dyspnea
Acute dyspneaAcute dyspnea
Acute dyspnea
 
Asthma ppt
Asthma pptAsthma ppt
Asthma ppt
 
childhood asthma
childhood asthmachildhood asthma
childhood asthma
 
Copd
CopdCopd
Copd
 
Wheeze in Children
Wheeze in ChildrenWheeze in Children
Wheeze in Children
 
Management of acute asthma in adults
Management of acute asthma in adultsManagement of acute asthma in adults
Management of acute asthma in adults
 
Acute exacerbation of COPD
Acute exacerbation of COPDAcute exacerbation of COPD
Acute exacerbation of COPD
 
Acute exacerbation of asthma
Acute exacerbation of asthmaAcute exacerbation of asthma
Acute exacerbation of asthma
 
Asthma
AsthmaAsthma
Asthma
 
Atelectasis
AtelectasisAtelectasis
Atelectasis
 
Mech Vent monitoring
Mech Vent monitoringMech Vent monitoring
Mech Vent monitoring
 
Hyperosmolar hyperglycemic state
Hyperosmolar hyperglycemic stateHyperosmolar hyperglycemic state
Hyperosmolar hyperglycemic state
 
Child with cyanosis
Child with cyanosisChild with cyanosis
Child with cyanosis
 

Similar to Management of Bronchial asthma from home to icu

Management of asthma exacerbation in children
Management of asthma exacerbation in childrenManagement of asthma exacerbation in children
Management of asthma exacerbation in childrenAzad Haleem
 
Management of Bronchial asthma exacerbation in children
Management of Bronchial asthma exacerbation in childrenManagement of Bronchial asthma exacerbation in children
Management of Bronchial asthma exacerbation in childrenAzad Haleem
 
Asthma and COPD exacerbation - Emergency
Asthma and COPD exacerbation - Emergency  Asthma and COPD exacerbation - Emergency
Asthma and COPD exacerbation - Emergency Areej Abu Hanieh
 
Asthma in the emergency department
Asthma in the emergency departmentAsthma in the emergency department
Asthma in the emergency departmentAmr Eldakroury
 
Status asthmaticus ancy ppt
Status asthmaticus ancy pptStatus asthmaticus ancy ppt
Status asthmaticus ancy pptancy143
 
Asthma management RAJEEV BAHALL
Asthma management RAJEEV BAHALLAsthma management RAJEEV BAHALL
Asthma management RAJEEV BAHALLRajeev Bahall
 
Acute Respiratory Distress Syndrome - GROUP 3.pptx
Acute Respiratory Distress Syndrome - GROUP 3.pptxAcute Respiratory Distress Syndrome - GROUP 3.pptx
Acute Respiratory Distress Syndrome - GROUP 3.pptxRexBlancoNuez
 
Dr.Zahid Ali Asthma.pptx
Dr.Zahid Ali Asthma.pptxDr.Zahid Ali Asthma.pptx
Dr.Zahid Ali Asthma.pptxMuhammad Azeem
 
Management of Asthma at Primary Care Level
Management of Asthma at Primary Care LevelManagement of Asthma at Primary Care Level
Management of Asthma at Primary Care LevelRedzwan Abdullah
 
complications of anesthesia.pptx
complications of anesthesia.pptxcomplications of anesthesia.pptx
complications of anesthesia.pptxGkPlexus
 
Asthmatic presentation description pptxy
Asthmatic presentation description pptxyAsthmatic presentation description pptxy
Asthmatic presentation description pptxyAmos830559
 
Asthma Review - GINA guidelines summary 2024
Asthma Review - GINA guidelines summary 2024Asthma Review - GINA guidelines summary 2024
Asthma Review - GINA guidelines summary 2024Gabriel Guevara MD
 
Acute_Asthma_Feb_2022.pptx
Acute_Asthma_Feb_2022.pptxAcute_Asthma_Feb_2022.pptx
Acute_Asthma_Feb_2022.pptxelizadoyce1
 
Acute asthma in children 2017
Acute asthma in children 2017Acute asthma in children 2017
Acute asthma in children 2017Ashraf ElAdawy
 
Part I. Management of Asthma-1(1).pptx
Part I. Management of Asthma-1(1).pptxPart I. Management of Asthma-1(1).pptx
Part I. Management of Asthma-1(1).pptxImanuIliyas
 
Management of bronchial asthma
Management of bronchial asthmaManagement of bronchial asthma
Management of bronchial asthmaAzad Haleem
 

Similar to Management of Bronchial asthma from home to icu (20)

Management of asthma exacerbation in children
Management of asthma exacerbation in childrenManagement of asthma exacerbation in children
Management of asthma exacerbation in children
 
Management of Bronchial asthma exacerbation in children
Management of Bronchial asthma exacerbation in childrenManagement of Bronchial asthma exacerbation in children
Management of Bronchial asthma exacerbation in children
 
Asthma and COPD exacerbation - Emergency
Asthma and COPD exacerbation - Emergency  Asthma and COPD exacerbation - Emergency
Asthma and COPD exacerbation - Emergency
 
Asthma in the emergency department
Asthma in the emergency departmentAsthma in the emergency department
Asthma in the emergency department
 
Status asthmaticus ancy ppt
Status asthmaticus ancy pptStatus asthmaticus ancy ppt
Status asthmaticus ancy ppt
 
Acute severe Asthma case presentation
Acute severe Asthma case presentationAcute severe Asthma case presentation
Acute severe Asthma case presentation
 
Asthma
AsthmaAsthma
Asthma
 
Asthma.pptx
Asthma.pptxAsthma.pptx
Asthma.pptx
 
Asthma management RAJEEV BAHALL
Asthma management RAJEEV BAHALLAsthma management RAJEEV BAHALL
Asthma management RAJEEV BAHALL
 
Acute Respiratory Distress Syndrome - GROUP 3.pptx
Acute Respiratory Distress Syndrome - GROUP 3.pptxAcute Respiratory Distress Syndrome - GROUP 3.pptx
Acute Respiratory Distress Syndrome - GROUP 3.pptx
 
Dr.Zahid Ali Asthma.pptx
Dr.Zahid Ali Asthma.pptxDr.Zahid Ali Asthma.pptx
Dr.Zahid Ali Asthma.pptx
 
Management of Asthma at Primary Care Level
Management of Asthma at Primary Care LevelManagement of Asthma at Primary Care Level
Management of Asthma at Primary Care Level
 
complications of anesthesia.pptx
complications of anesthesia.pptxcomplications of anesthesia.pptx
complications of anesthesia.pptx
 
Asthmatic presentation description pptxy
Asthmatic presentation description pptxyAsthmatic presentation description pptxy
Asthmatic presentation description pptxy
 
Acute asthma
Acute asthmaAcute asthma
Acute asthma
 
Asthma Review - GINA guidelines summary 2024
Asthma Review - GINA guidelines summary 2024Asthma Review - GINA guidelines summary 2024
Asthma Review - GINA guidelines summary 2024
 
Acute_Asthma_Feb_2022.pptx
Acute_Asthma_Feb_2022.pptxAcute_Asthma_Feb_2022.pptx
Acute_Asthma_Feb_2022.pptx
 
Acute asthma in children 2017
Acute asthma in children 2017Acute asthma in children 2017
Acute asthma in children 2017
 
Part I. Management of Asthma-1(1).pptx
Part I. Management of Asthma-1(1).pptxPart I. Management of Asthma-1(1).pptx
Part I. Management of Asthma-1(1).pptx
 
Management of bronchial asthma
Management of bronchial asthmaManagement of bronchial asthma
Management of bronchial asthma
 

More from Azad Haleem

Pediatric Pharmacology:Pharmacokinetics and pharmacodynamics .pptx
Pediatric  Pharmacology:Pharmacokinetics and pharmacodynamics  .pptxPediatric  Pharmacology:Pharmacokinetics and pharmacodynamics  .pptx
Pediatric Pharmacology:Pharmacokinetics and pharmacodynamics .pptxAzad Haleem
 
Neonatal Hypoglycemia approach and Management .pptx
Neonatal Hypoglycemia approach and Management .pptxNeonatal Hypoglycemia approach and Management .pptx
Neonatal Hypoglycemia approach and Management .pptxAzad Haleem
 
Preterm infants Nutrition .pptx
Preterm infants Nutrition .pptxPreterm infants Nutrition .pptx
Preterm infants Nutrition .pptxAzad Haleem
 
Preterm : ABCDE; approach to nutritional assessment in preterm infants.pptx
Preterm : ABCDE; approach to nutritional assessment in preterm infants.pptxPreterm : ABCDE; approach to nutritional assessment in preterm infants.pptx
Preterm : ABCDE; approach to nutritional assessment in preterm infants.pptxAzad Haleem
 
Breastfeeding VS formula feeding .pptx
 Breastfeeding VS formula feeding .pptx Breastfeeding VS formula feeding .pptx
Breastfeeding VS formula feeding .pptxAzad Haleem
 
Role of Supplements in Growth Failure in Children .pptx
Role of Supplements in Growth Failure in Children .pptxRole of Supplements in Growth Failure in Children .pptx
Role of Supplements in Growth Failure in Children .pptxAzad Haleem
 
Degludec Insulin therapy in children
Degludec Insulin therapy in childrenDegludec Insulin therapy in children
Degludec Insulin therapy in childrenAzad Haleem
 
Viral hemorrhagic fevers.pptx
Viral hemorrhagic fevers.pptxViral hemorrhagic fevers.pptx
Viral hemorrhagic fevers.pptxAzad Haleem
 
Micronutrient deficiencies in children .pptx
 Micronutrient deficiencies in children  .pptx Micronutrient deficiencies in children  .pptx
Micronutrient deficiencies in children .pptxAzad Haleem
 
Insulin therapy in children.pptx
Insulin therapy in children.pptxInsulin therapy in children.pptx
Insulin therapy in children.pptxAzad Haleem
 
Diagnostic test for testicular and ovarian disorders in children 2.pptx
Diagnostic test for testicular and ovarian disorders in children 2.pptxDiagnostic test for testicular and ovarian disorders in children 2.pptx
Diagnostic test for testicular and ovarian disorders in children 2.pptxAzad Haleem
 
Diagnostic test for Adrenal disorders in children 2.pptx
Diagnostic test for Adrenal disorders in children 2.pptxDiagnostic test for Adrenal disorders in children 2.pptx
Diagnostic test for Adrenal disorders in children 2.pptxAzad Haleem
 
Diagnostic test for Thyriod disorders in children.pptx
Diagnostic test for Thyriod disorders in children.pptxDiagnostic test for Thyriod disorders in children.pptx
Diagnostic test for Thyriod disorders in children.pptxAzad Haleem
 
Achondroplasia in children.pptx
Achondroplasia in children.pptxAchondroplasia in children.pptx
Achondroplasia in children.pptxAzad Haleem
 
Respiratory Syncytial Virus in children
Respiratory Syncytial Virus in childrenRespiratory Syncytial Virus in children
Respiratory Syncytial Virus in childrenAzad Haleem
 
Growth failure in Children.pptx
Growth failure in Children.pptxGrowth failure in Children.pptx
Growth failure in Children.pptxAzad Haleem
 
Adenoid Enlargement in children.pptx
Adenoid Enlargement in children.pptxAdenoid Enlargement in children.pptx
Adenoid Enlargement in children.pptxAzad Haleem
 
Postbiotics in children
 Postbiotics in children Postbiotics in children
Postbiotics in childrenAzad Haleem
 
Bronchial Asthma in children .pptx
Bronchial Asthma in children .pptxBronchial Asthma in children .pptx
Bronchial Asthma in children .pptxAzad Haleem
 
Fever in Children .pptx
Fever in Children .pptxFever in Children .pptx
Fever in Children .pptxAzad Haleem
 

More from Azad Haleem (20)

Pediatric Pharmacology:Pharmacokinetics and pharmacodynamics .pptx
Pediatric  Pharmacology:Pharmacokinetics and pharmacodynamics  .pptxPediatric  Pharmacology:Pharmacokinetics and pharmacodynamics  .pptx
Pediatric Pharmacology:Pharmacokinetics and pharmacodynamics .pptx
 
Neonatal Hypoglycemia approach and Management .pptx
Neonatal Hypoglycemia approach and Management .pptxNeonatal Hypoglycemia approach and Management .pptx
Neonatal Hypoglycemia approach and Management .pptx
 
Preterm infants Nutrition .pptx
Preterm infants Nutrition .pptxPreterm infants Nutrition .pptx
Preterm infants Nutrition .pptx
 
Preterm : ABCDE; approach to nutritional assessment in preterm infants.pptx
Preterm : ABCDE; approach to nutritional assessment in preterm infants.pptxPreterm : ABCDE; approach to nutritional assessment in preterm infants.pptx
Preterm : ABCDE; approach to nutritional assessment in preterm infants.pptx
 
Breastfeeding VS formula feeding .pptx
 Breastfeeding VS formula feeding .pptx Breastfeeding VS formula feeding .pptx
Breastfeeding VS formula feeding .pptx
 
Role of Supplements in Growth Failure in Children .pptx
Role of Supplements in Growth Failure in Children .pptxRole of Supplements in Growth Failure in Children .pptx
Role of Supplements in Growth Failure in Children .pptx
 
Degludec Insulin therapy in children
Degludec Insulin therapy in childrenDegludec Insulin therapy in children
Degludec Insulin therapy in children
 
Viral hemorrhagic fevers.pptx
Viral hemorrhagic fevers.pptxViral hemorrhagic fevers.pptx
Viral hemorrhagic fevers.pptx
 
Micronutrient deficiencies in children .pptx
 Micronutrient deficiencies in children  .pptx Micronutrient deficiencies in children  .pptx
Micronutrient deficiencies in children .pptx
 
Insulin therapy in children.pptx
Insulin therapy in children.pptxInsulin therapy in children.pptx
Insulin therapy in children.pptx
 
Diagnostic test for testicular and ovarian disorders in children 2.pptx
Diagnostic test for testicular and ovarian disorders in children 2.pptxDiagnostic test for testicular and ovarian disorders in children 2.pptx
Diagnostic test for testicular and ovarian disorders in children 2.pptx
 
Diagnostic test for Adrenal disorders in children 2.pptx
Diagnostic test for Adrenal disorders in children 2.pptxDiagnostic test for Adrenal disorders in children 2.pptx
Diagnostic test for Adrenal disorders in children 2.pptx
 
Diagnostic test for Thyriod disorders in children.pptx
Diagnostic test for Thyriod disorders in children.pptxDiagnostic test for Thyriod disorders in children.pptx
Diagnostic test for Thyriod disorders in children.pptx
 
Achondroplasia in children.pptx
Achondroplasia in children.pptxAchondroplasia in children.pptx
Achondroplasia in children.pptx
 
Respiratory Syncytial Virus in children
Respiratory Syncytial Virus in childrenRespiratory Syncytial Virus in children
Respiratory Syncytial Virus in children
 
Growth failure in Children.pptx
Growth failure in Children.pptxGrowth failure in Children.pptx
Growth failure in Children.pptx
 
Adenoid Enlargement in children.pptx
Adenoid Enlargement in children.pptxAdenoid Enlargement in children.pptx
Adenoid Enlargement in children.pptx
 
Postbiotics in children
 Postbiotics in children Postbiotics in children
Postbiotics in children
 
Bronchial Asthma in children .pptx
Bronchial Asthma in children .pptxBronchial Asthma in children .pptx
Bronchial Asthma in children .pptx
 
Fever in Children .pptx
Fever in Children .pptxFever in Children .pptx
Fever in Children .pptx
 

Recently uploaded

Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Celine George
 
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfGrade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfJemuel Francisco
 
What is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPWhat is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPCeline George
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptxmary850239
 
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfLike-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfMr Bounab Samir
 
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdfAMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdfphamnguyenenglishnb
 
Culture Uniformity or Diversity IN SOCIOLOGY.pptx
Culture Uniformity or Diversity IN SOCIOLOGY.pptxCulture Uniformity or Diversity IN SOCIOLOGY.pptx
Culture Uniformity or Diversity IN SOCIOLOGY.pptxPoojaSen20
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxiammrhaywood
 
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...Nguyen Thanh Tu Collection
 
Judging the Relevance and worth of ideas part 2.pptx
Judging the Relevance  and worth of ideas part 2.pptxJudging the Relevance  and worth of ideas part 2.pptx
Judging the Relevance and worth of ideas part 2.pptxSherlyMaeNeri
 
AUDIENCE THEORY -CULTIVATION THEORY - GERBNER.pptx
AUDIENCE THEORY -CULTIVATION THEORY -  GERBNER.pptxAUDIENCE THEORY -CULTIVATION THEORY -  GERBNER.pptx
AUDIENCE THEORY -CULTIVATION THEORY - GERBNER.pptxiammrhaywood
 
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)lakshayb543
 
Barangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptxBarangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptxCarlos105
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatYousafMalik24
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxHumphrey A Beña
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designMIPLM
 
How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17Celine George
 

Recently uploaded (20)

Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
 
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfGrade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
 
What is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPWhat is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERP
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx
 
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfLike-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
 
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdfAMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
 
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptxFINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
 
Culture Uniformity or Diversity IN SOCIOLOGY.pptx
Culture Uniformity or Diversity IN SOCIOLOGY.pptxCulture Uniformity or Diversity IN SOCIOLOGY.pptx
Culture Uniformity or Diversity IN SOCIOLOGY.pptx
 
Raw materials used in Herbal Cosmetics.pptx
Raw materials used in Herbal Cosmetics.pptxRaw materials used in Herbal Cosmetics.pptx
Raw materials used in Herbal Cosmetics.pptx
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
 
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptxLEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
 
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
 
Judging the Relevance and worth of ideas part 2.pptx
Judging the Relevance  and worth of ideas part 2.pptxJudging the Relevance  and worth of ideas part 2.pptx
Judging the Relevance and worth of ideas part 2.pptx
 
AUDIENCE THEORY -CULTIVATION THEORY - GERBNER.pptx
AUDIENCE THEORY -CULTIVATION THEORY -  GERBNER.pptxAUDIENCE THEORY -CULTIVATION THEORY -  GERBNER.pptx
AUDIENCE THEORY -CULTIVATION THEORY - GERBNER.pptx
 
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
 
Barangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptxBarangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptx
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice great
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-design
 
How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17
 

Management of Bronchial asthma from home to icu

  • 1.
  • 2. Acute Asthma Exacerbation: • Bronchial Asthma : consist of broncho spasm & airway inflammation. • Asthma exacerbations consist of acute or subacute episodes of progressively worsening shortness of breath, coughing, wheezing, and chest tightness or any combination thereof.
  • 3. Clinical Assessment • Focused History. • Physical examination findings: vital signs, Respiratory distress& Chest examination. • Pulse oximetry & PEFR • Lung function (defer in patients with moderate to severe distress or history of labile disease)
  • 4. • Often, asthma exacerbations worsen during sleep (between midnight and 8 am), when airways inflammation and hyperresponsiveness are at their peak. • A severe exacerbation of asthma that does not improve with standard therapy is termed status asthmaticus. • The biologic, environmental, economic, and psychosocial risk factors associated with asthma morbidity and death can further guide this assessment. Acute Asthma Exacerbation:
  • 5. Acute Asthma Exacerbation: Assessment and Severity • Severity range: mild  mod severe • Treatment : outpatient, inpatient (floor or ICU) • Severity: Clinical, ABG, PEFR ( ≥ 70%, 40-69%, < 40%) • A chest radiograph is not recommended for routine assessment but should be obtained for patients suspected of having congestive heart failure, pneumothorax/mediastinum, pneumonia.
  • 7. In general ???  There are two main types of drugs used for treating asthma. Medications to reduce bronchoconstrictions: o Beta 2 Agonist o Anticholinergics o Theophylline Medications to reduce inflammations: o Steroids ( oral, Parenteral & Inhalers) o Not steroids: • Leukotriene modifiers ( montelukast is available worldwide; zafirlukast and pranlukast only in Japanese Guideline for Childhood Asthma(JGCA).  Cromolyn & Nedocromil (Reduction of mast cell degranulation)
  • 8. Farther more ???  Quick- relief medications: o Short acting Beta Agonists (SABA’s) o Systemic corticosteroids o Anticholinergics  Long-term control medications: o Corticosteroids (mainly ICS, occasionally OCS). o Long Acting Beta Agonists (LABA’s) including salmeterol and formoterol, o Leukotriene Modifiers (LTM) o Cromolyn & Nedocromil o Methylxanthines: (Sustained-release theophylline)
  • 10. Case scenario ? • Ali 10 years old , a known case of bronchial asthma • Develop cough and SOB for 12 hours duration after flue like illness & exposure to smock. • O/E: in respiratory distress.
  • 11. Home Management of Asthma Exacerbations • Families of all children with asthma should have a written action plan. • A written home action plan can reduce the risk of asthma death by 70%. • The NIH guidelines recommend immediate treatment with “rescue” medication (inhaled SABA, up to 3 treatments in 1 hr). • A good response is characterized by: resolution of symptoms within 1hr, no further symptoms over the next 4 hr.
  • 12. Farther more …. • Ali become better but still have cough & SOB & bronchodilators are required repeatedly over the next 24 hr.
  • 13. • The child's physician should be contacted for follow-up, especially if bronchodilators are required repeatedly over the next 24-48 hr. • Short course of oral corticosteroid therapy (prednisone 1-2 mg/kg/day for 4 days) in addition to inhaled β-agonist therapy should be instituted. Home Management of Asthma Exacerbations
  • 14. Ali develop severe exacerbations& deterioration persistent signs of respiratory distress, lack of expected response or sustained improvement after initial treatment, Immediate medical attention should be sought for: ( call 122 ) Home Management of Asthma Exacerbations
  • 15. • Initial treatment includes: • supplemental oxygen, • inhaled β-agonist therapy every 20 min for 1 hr, and, • systemic corticosteroids given either orally or intravenously. • Close monitoring of clinical status, hydration, and oxygenation are essential elements of immediate management. Emergency Department Management of Asthma Exacerbations
  • 16. • The patient may be discharged to home if there is sustained improvement in symptoms, normal physical findings, an oxygen saturation >92% while the patient is breathing room air for 4 hr. • Discharge medications include administration of an inhaled β-agonist up to every 4 hr plus a 3-to 7-day course of an oral corticosteroid. • Optimizing controller therapy before discharge is also recommended. Emergency Department Management of Asthma Exacerbations
  • 17. • Ali has poor response to intensified treatment suggests that the exacerbation will not remit quickly. • Inhaled ipratropium: added to the β-agonist & corticosteroid treatment. Emergency Department Management of Asthma Exacerbations
  • 18. Hospital Management of Asthma Exacerbations • Ali does not adequately improve within 2 hr of emergency department treatment, admission to the hospital, at least overnight, is likely to be needed. • β-agonist up to every 4 hr • Inhaled ipratropium 6 hr • Corticosteroid IV (Oral)
  • 19. • Ali deteriorated at unit & developed severe respiratory distress, poor response to therapy, and concern for potential respiratory failure and arrest. He need admission to an intensive care unit Hospital Management (ICU)of Asthma Exacerbations
  • 20. Ali : require additional evaluations, such as complete blood cell counts, measurements of arterial blood gases and serum electrolytes, and chest radiograph, to monitor for respiratory insufficiency, co- morbidities, infection, and/or dehydration. Hospital Management of Asthma Exacerbations
  • 21. • the conventional interventions for status asthmaticus are: • Supplemental oxygen, high-flow oxygen. • SABAs can be delivered frequently (every 20 min) • May need intravenous β-agonist therapy. • Inhaled ipratropium bromide every 6 hr. • systemic corticosteroid therapy • Patients requiring cardiac monitoring & oximetry. Hospital Management of Asthma Exacerbations
  • 22. Nelson Textbook of Pediatrics, 20th edition, page 1114. According to Nelson Textbook of Pediatrics, 21th edition 2019  The addition of ICS to a course of oral corticosteroid in the emergency setting , reduces the risk of exacerbation recurrence over the subsequent month.
  • 23. • Hydration status monitoring is especially important (insensible losses) and decreased oral intake but • Further complicating this situation is the association of increased antidiuretic hormone (ADH) secretion with status asthmaticus. • Administration of fluids at or slightly below maintenance fluid requirements is recommended. • Chest physical therapy, and mucolytics are not recommended . Hospital Management of Asthma Exacerbations
  • 24. • Despite intensive therapy, some asthmatic children remain critically ill and at risk for respiratory failure, intubation, and mechanical ventilation. • Complications (air leaks) related to asthma exacerbations increase with intubation and assisted ventilation; every effort should be made to relieve bronchospasm and prevent respiratory failure. Hospital Management of Asthma Exacerbations
  • 25. • Several therapies, including parenterally administered • Epinephrine: Parenteral (subcutaneous, intramuscular, or intravenous) epinephrine may be effective in patients with life- threatening obstruction that is not responding to high doses of inhaled β-agonists, because in such patients, inhaled medication may not reach the lower airway. • methylxanthines, • magnesium sulfate (25-75 mg/kg, maximum dose 2.5 g, given intravenously over 20 min), and • inhaled heliox have demonstrated some benefit as adjunctive therapies in patients with severe status asthmaticus. • Administration of either methylxanthine or magnesium sulfate requires monitoring of serum levels and cardiovascular status. Hospital Management of Asthma Exacerbations
  • 26. • Volume-cycled ventilators, using • short inspiratory and long expiratory times, • 10-15 mL/kg tidal volume, • 8-15 breaths/min, • peak pressures < 60 cm H2O, and without positive end-expiratory pressure are starting mechanical ventilation parameters that can achieve these goals. Hospital Management of Asthma Exacerbations
  • 27. • In children, management of severe exacerbations in medical centers is usually successful, even when extreme measures are required. • A follow-up appointment within 1 to 2 wk of a child's discharge from the hospital after resolution of an asthma exacerbation should be used to monitor clinical improvement and to reinforce key educational elements, including action plans and controller medications. Hospital Management of Asthma Exacerbations